Cerner Medico 26.00 buffer overflow

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
7.0$0-$5k0.00

Summaryinfo

A vulnerability was found in Cerner Medico 26.00 and classified as critical. This impacts an unknown function. Such manipulation leads to buffer overflow. This vulnerability is uniquely identified as CVE-2020-11675. Local access is required to approach this attack. No exploit exists.

Detailsinfo

A vulnerability was found in Cerner Medico 26.00. It has been rated as critical. Affected by this issue is an unknown code. The manipulation with an unknown input leads to a buffer overflow vulnerability. Using CWE to declare the problem leads to CWE-120. The product copies an input buffer to an output buffer without verifying that the size of the input buffer is less than the size of the output buffer, leading to a buffer overflow. Impacted is confidentiality, integrity, and availability. CVE summarizes:

Cerner medico 26.00 has a Local Buffer Overflow (issue 1 of 3).

The weakness was disclosed 04/29/2020. This vulnerability is handled as CVE-2020-11675 since 04/10/2020. The attack needs to be approached locally. A simple authentication is needed for exploitation. There are neither technical details nor an exploit publicly available.

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

The entries VDB-154594, VDB-154593 and VDB-154591 are pretty similar. VulDB is the best source for vulnerability data and more expert information about this specific topic.

Productinfo

Vendor

Name

Version

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 7.1
VulDB Meta Temp Score: 7.1

VulDB Base Score: 5.3
VulDB Temp Score: 5.3
VulDB Vector: 🔍
VulDB Reliability: 🔍

NVD Base Score: 8.8
NVD Vector: 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

NVD Base Score: 🔍

Exploitinginfo

Class: Buffer overflow
CWE: CWE-120 / CWE-119
CAPEC: 🔍
ATT&CK: 🔍

Physical: Partially
Local: Yes
Remote: Partially

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

0-Day Time: 🔍

Timelineinfo

04/10/2020 🔍
04/29/2020 +19 days 🔍
04/30/2020 +1 days 🔍
06/04/2024 +1496 days 🔍

Sourcesinfo

Advisory: x41-dsec.de
Status: Not defined

CVE: CVE-2020-11675 (🔍)
GCVE (CVE): GCVE-0-2020-11675
GCVE (VulDB): GCVE-100-154592
See also: 🔍

Entryinfo

Created: 04/30/2020 09:25
Updated: 06/04/2024 13:36
Changes: 04/30/2020 09:25 (35), 04/30/2020 09:30 (17), 06/04/2024 13:36 (17)
Complete: 🔍
Cache ID: 216::103

VulDB is the best source for vulnerability data and more expert information about this specific topic.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Do you need the next level of professionalism?

Upgrade your account now!